nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—CYP3A4—bone cancer	0.64	1	CbGaD
Rivastigmine—BCHE—Cisplatin—bone cancer	0.111	0.792	CbGbCtD
Rivastigmine—CYP2D6—Doxorubicin—bone cancer	0.0178	0.127	CbGbCtD
Rivastigmine—CYP3A4—Doxorubicin—bone cancer	0.0113	0.0807	CbGbCtD
Rivastigmine—Pyridostigmine—CYP3A4—bone cancer	0.00301	1	CrCbGaD
Rivastigmine—Visual impairment—Methotrexate—bone cancer	0.000164	0.000757	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000163	0.000751	CcSEcCtD
Rivastigmine—Hypersensitivity—Cisplatin—bone cancer	0.000163	0.000749	CcSEcCtD
Rivastigmine—Bradycardia—Epirubicin—bone cancer	0.000163	0.000748	CcSEcCtD
Rivastigmine—Renal failure—Doxorubicin—bone cancer	0.000162	0.000745	CcSEcCtD
Rivastigmine—Erythema multiforme—Methotrexate—bone cancer	0.000161	0.000743	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Doxorubicin—bone cancer	0.000161	0.000743	CcSEcCtD
Rivastigmine—Haemoglobin—Epirubicin—bone cancer	0.000161	0.000739	CcSEcCtD
Rivastigmine—Rhinitis—Epirubicin—bone cancer	0.00016	0.000737	CcSEcCtD
Rivastigmine—Urinary tract infection—Doxorubicin—bone cancer	0.00016	0.000737	CcSEcCtD
Rivastigmine—Conjunctivitis—Doxorubicin—bone cancer	0.00016	0.000737	CcSEcCtD
Rivastigmine—Hepatitis—Epirubicin—bone cancer	0.00016	0.000735	CcSEcCtD
Rivastigmine—Haemorrhage—Epirubicin—bone cancer	0.00016	0.000735	CcSEcCtD
Rivastigmine—Eye disorder—Methotrexate—bone cancer	0.00016	0.000734	CcSEcCtD
Rivastigmine—Tinnitus—Methotrexate—bone cancer	0.000159	0.000732	CcSEcCtD
Rivastigmine—Hypoaesthesia—Epirubicin—bone cancer	0.000159	0.000731	CcSEcCtD
Rivastigmine—Asthenia—Cisplatin—bone cancer	0.000159	0.00073	CcSEcCtD
Rivastigmine—Pharyngitis—Epirubicin—bone cancer	0.000159	0.00073	CcSEcCtD
Rivastigmine—Cardiac disorder—Methotrexate—bone cancer	0.000158	0.000729	CcSEcCtD
Rivastigmine—Sweating—Doxorubicin—bone cancer	0.000158	0.000726	CcSEcCtD
Rivastigmine—Urinary tract disorder—Epirubicin—bone cancer	0.000158	0.000726	CcSEcCtD
Rivastigmine—Oedema peripheral—Epirubicin—bone cancer	0.000157	0.000724	CcSEcCtD
Rivastigmine—Haematuria—Doxorubicin—bone cancer	0.000157	0.000722	CcSEcCtD
Rivastigmine—Connective tissue disorder—Epirubicin—bone cancer	0.000157	0.000722	CcSEcCtD
Rivastigmine—Urethral disorder—Epirubicin—bone cancer	0.000157	0.000721	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Doxorubicin—bone cancer	0.000156	0.000717	CcSEcCtD
Rivastigmine—Epistaxis—Doxorubicin—bone cancer	0.000155	0.000715	CcSEcCtD
Rivastigmine—Angiopathy—Methotrexate—bone cancer	0.000155	0.000713	CcSEcCtD
Rivastigmine—Sinusitis—Doxorubicin—bone cancer	0.000154	0.000711	CcSEcCtD
Rivastigmine—Visual impairment—Epirubicin—bone cancer	0.000154	0.000708	CcSEcCtD
Rivastigmine—Mediastinal disorder—Methotrexate—bone cancer	0.000154	0.000708	CcSEcCtD
Rivastigmine—Chills—Methotrexate—bone cancer	0.000153	0.000705	CcSEcCtD
Rivastigmine—Diarrhoea—Cisplatin—bone cancer	0.000151	0.000696	CcSEcCtD
Rivastigmine—Erythema multiforme—Epirubicin—bone cancer	0.000151	0.000695	CcSEcCtD
Rivastigmine—Alopecia—Methotrexate—bone cancer	0.000151	0.000694	CcSEcCtD
Rivastigmine—Bradycardia—Doxorubicin—bone cancer	0.00015	0.000692	CcSEcCtD
Rivastigmine—Mental disorder—Methotrexate—bone cancer	0.00015	0.000688	CcSEcCtD
Rivastigmine—Eye disorder—Epirubicin—bone cancer	0.000149	0.000687	CcSEcCtD
Rivastigmine—Tinnitus—Epirubicin—bone cancer	0.000149	0.000685	CcSEcCtD
Rivastigmine—Erythema—Methotrexate—bone cancer	0.000149	0.000684	CcSEcCtD
Rivastigmine—Malnutrition—Methotrexate—bone cancer	0.000149	0.000684	CcSEcCtD
Rivastigmine—Haemoglobin—Doxorubicin—bone cancer	0.000149	0.000684	CcSEcCtD
Rivastigmine—Cardiac disorder—Epirubicin—bone cancer	0.000148	0.000682	CcSEcCtD
Rivastigmine—Flushing—Epirubicin—bone cancer	0.000148	0.000682	CcSEcCtD
Rivastigmine—Rhinitis—Doxorubicin—bone cancer	0.000148	0.000682	CcSEcCtD
Rivastigmine—Haemorrhage—Doxorubicin—bone cancer	0.000148	0.00068	CcSEcCtD
Rivastigmine—Hepatitis—Doxorubicin—bone cancer	0.000148	0.00068	CcSEcCtD
Rivastigmine—Hypoaesthesia—Doxorubicin—bone cancer	0.000147	0.000677	CcSEcCtD
Rivastigmine—Pharyngitis—Doxorubicin—bone cancer	0.000147	0.000675	CcSEcCtD
Rivastigmine—Urinary tract disorder—Doxorubicin—bone cancer	0.000146	0.000672	CcSEcCtD
Rivastigmine—Oedema peripheral—Doxorubicin—bone cancer	0.000146	0.00067	CcSEcCtD
Rivastigmine—Dysgeusia—Methotrexate—bone cancer	0.000145	0.00067	CcSEcCtD
Rivastigmine—Connective tissue disorder—Doxorubicin—bone cancer	0.000145	0.000668	CcSEcCtD
Rivastigmine—Angiopathy—Epirubicin—bone cancer	0.000145	0.000667	CcSEcCtD
Rivastigmine—Urethral disorder—Doxorubicin—bone cancer	0.000145	0.000667	CcSEcCtD
Rivastigmine—Mediastinal disorder—Epirubicin—bone cancer	0.000144	0.000663	CcSEcCtD
Rivastigmine—Back pain—Methotrexate—bone cancer	0.000144	0.000661	CcSEcCtD
Rivastigmine—Chills—Epirubicin—bone cancer	0.000143	0.00066	CcSEcCtD
Rivastigmine—Arrhythmia—Epirubicin—bone cancer	0.000143	0.000657	CcSEcCtD
Rivastigmine—Visual impairment—Doxorubicin—bone cancer	0.000142	0.000655	CcSEcCtD
Rivastigmine—Alopecia—Epirubicin—bone cancer	0.000141	0.00065	CcSEcCtD
Rivastigmine—Vomiting—Cisplatin—bone cancer	0.00014	0.000647	CcSEcCtD
Rivastigmine—Vision blurred—Methotrexate—bone cancer	0.00014	0.000644	CcSEcCtD
Rivastigmine—Mental disorder—Epirubicin—bone cancer	0.00014	0.000644	CcSEcCtD
Rivastigmine—Erythema multiforme—Doxorubicin—bone cancer	0.00014	0.000643	CcSEcCtD
Rivastigmine—Rash—Cisplatin—bone cancer	0.000139	0.000641	CcSEcCtD
Rivastigmine—Dermatitis—Cisplatin—bone cancer	0.000139	0.000641	CcSEcCtD
Rivastigmine—Erythema—Epirubicin—bone cancer	0.000139	0.00064	CcSEcCtD
Rivastigmine—Malnutrition—Epirubicin—bone cancer	0.000139	0.00064	CcSEcCtD
Rivastigmine—Eye disorder—Doxorubicin—bone cancer	0.000138	0.000636	CcSEcCtD
Rivastigmine—Ill-defined disorder—Methotrexate—bone cancer	0.000138	0.000634	CcSEcCtD
Rivastigmine—Tinnitus—Doxorubicin—bone cancer	0.000138	0.000634	CcSEcCtD
Rivastigmine—Anaemia—Methotrexate—bone cancer	0.000137	0.000632	CcSEcCtD
Rivastigmine—Cardiac disorder—Doxorubicin—bone cancer	0.000137	0.000631	CcSEcCtD
Rivastigmine—Flushing—Doxorubicin—bone cancer	0.000137	0.000631	CcSEcCtD
Rivastigmine—Flatulence—Epirubicin—bone cancer	0.000137	0.000631	CcSEcCtD
Rivastigmine—Tension—Epirubicin—bone cancer	0.000136	0.000628	CcSEcCtD
Rivastigmine—Dysgeusia—Epirubicin—bone cancer	0.000136	0.000627	CcSEcCtD
Rivastigmine—Nervousness—Epirubicin—bone cancer	0.000135	0.000622	CcSEcCtD
Rivastigmine—Back pain—Epirubicin—bone cancer	0.000134	0.000619	CcSEcCtD
Rivastigmine—Angiopathy—Doxorubicin—bone cancer	0.000134	0.000617	CcSEcCtD
Rivastigmine—Malaise—Methotrexate—bone cancer	0.000134	0.000617	CcSEcCtD
Rivastigmine—Muscle spasms—Epirubicin—bone cancer	0.000134	0.000615	CcSEcCtD
Rivastigmine—Vertigo—Methotrexate—bone cancer	0.000133	0.000614	CcSEcCtD
Rivastigmine—Mediastinal disorder—Doxorubicin—bone cancer	0.000133	0.000613	CcSEcCtD
Rivastigmine—Chills—Doxorubicin—bone cancer	0.000133	0.00061	CcSEcCtD
Rivastigmine—Arrhythmia—Doxorubicin—bone cancer	0.000132	0.000608	CcSEcCtD
Rivastigmine—Nausea—Cisplatin—bone cancer	0.000131	0.000604	CcSEcCtD
Rivastigmine—Vision blurred—Epirubicin—bone cancer	0.000131	0.000603	CcSEcCtD
Rivastigmine—Alopecia—Doxorubicin—bone cancer	0.000131	0.000601	CcSEcCtD
Rivastigmine—Cough—Methotrexate—bone cancer	0.00013	0.000597	CcSEcCtD
Rivastigmine—Mental disorder—Doxorubicin—bone cancer	0.000129	0.000596	CcSEcCtD
Rivastigmine—Ill-defined disorder—Epirubicin—bone cancer	0.000129	0.000594	CcSEcCtD
Rivastigmine—Convulsion—Methotrexate—bone cancer	0.000129	0.000592	CcSEcCtD
Rivastigmine—Erythema—Doxorubicin—bone cancer	0.000129	0.000592	CcSEcCtD
Rivastigmine—Malnutrition—Doxorubicin—bone cancer	0.000129	0.000592	CcSEcCtD
Rivastigmine—Anaemia—Epirubicin—bone cancer	0.000129	0.000591	CcSEcCtD
Rivastigmine—Agitation—Epirubicin—bone cancer	0.000128	0.000588	CcSEcCtD
Rivastigmine—Flatulence—Doxorubicin—bone cancer	0.000127	0.000583	CcSEcCtD
Rivastigmine—Myalgia—Methotrexate—bone cancer	0.000126	0.000582	CcSEcCtD
Rivastigmine—Chest pain—Methotrexate—bone cancer	0.000126	0.000582	CcSEcCtD
Rivastigmine—Arthralgia—Methotrexate—bone cancer	0.000126	0.000582	CcSEcCtD
Rivastigmine—Tension—Doxorubicin—bone cancer	0.000126	0.000581	CcSEcCtD
Rivastigmine—Dysgeusia—Doxorubicin—bone cancer	0.000126	0.00058	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000126	0.000578	CcSEcCtD
Rivastigmine—Malaise—Epirubicin—bone cancer	0.000125	0.000577	CcSEcCtD
Rivastigmine—Discomfort—Methotrexate—bone cancer	0.000125	0.000575	CcSEcCtD
Rivastigmine—Nervousness—Doxorubicin—bone cancer	0.000125	0.000575	CcSEcCtD
Rivastigmine—Vertigo—Epirubicin—bone cancer	0.000125	0.000575	CcSEcCtD
Rivastigmine—Syncope—Epirubicin—bone cancer	0.000125	0.000574	CcSEcCtD
Rivastigmine—Back pain—Doxorubicin—bone cancer	0.000124	0.000573	CcSEcCtD
Rivastigmine—Muscle spasms—Doxorubicin—bone cancer	0.000124	0.000569	CcSEcCtD
Rivastigmine—Palpitations—Epirubicin—bone cancer	0.000123	0.000566	CcSEcCtD
Rivastigmine—Confusional state—Methotrexate—bone cancer	0.000122	0.000563	CcSEcCtD
Rivastigmine—Loss of consciousness—Epirubicin—bone cancer	0.000122	0.000562	CcSEcCtD
Rivastigmine—Cough—Epirubicin—bone cancer	0.000121	0.000558	CcSEcCtD
Rivastigmine—Vision blurred—Doxorubicin—bone cancer	0.000121	0.000558	CcSEcCtD
Rivastigmine—Convulsion—Epirubicin—bone cancer	0.00012	0.000554	CcSEcCtD
Rivastigmine—Infection—Methotrexate—bone cancer	0.00012	0.000554	CcSEcCtD
Rivastigmine—Hypertension—Epirubicin—bone cancer	0.00012	0.000552	CcSEcCtD
Rivastigmine—Ill-defined disorder—Doxorubicin—bone cancer	0.000119	0.000549	CcSEcCtD
Rivastigmine—Nervous system disorder—Methotrexate—bone cancer	0.000119	0.000547	CcSEcCtD
Rivastigmine—Anaemia—Doxorubicin—bone cancer	0.000119	0.000547	CcSEcCtD
Rivastigmine—Thrombocytopenia—Methotrexate—bone cancer	0.000119	0.000546	CcSEcCtD
Rivastigmine—Chest pain—Epirubicin—bone cancer	0.000118	0.000545	CcSEcCtD
Rivastigmine—Myalgia—Epirubicin—bone cancer	0.000118	0.000545	CcSEcCtD
Rivastigmine—Arthralgia—Epirubicin—bone cancer	0.000118	0.000545	CcSEcCtD
Rivastigmine—Agitation—Doxorubicin—bone cancer	0.000118	0.000544	CcSEcCtD
Rivastigmine—Anxiety—Epirubicin—bone cancer	0.000118	0.000543	CcSEcCtD
Rivastigmine—Skin disorder—Methotrexate—bone cancer	0.000118	0.000542	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000118	0.000541	CcSEcCtD
Rivastigmine—Hyperhidrosis—Methotrexate—bone cancer	0.000117	0.00054	CcSEcCtD
Rivastigmine—Discomfort—Epirubicin—bone cancer	0.000117	0.000538	CcSEcCtD
Rivastigmine—Malaise—Doxorubicin—bone cancer	0.000116	0.000534	CcSEcCtD
Rivastigmine—Dry mouth—Epirubicin—bone cancer	0.000116	0.000533	CcSEcCtD
Rivastigmine—Vertigo—Doxorubicin—bone cancer	0.000116	0.000532	CcSEcCtD
Rivastigmine—Anorexia—Methotrexate—bone cancer	0.000116	0.000532	CcSEcCtD
Rivastigmine—Syncope—Doxorubicin—bone cancer	0.000115	0.000531	CcSEcCtD
Rivastigmine—Confusional state—Epirubicin—bone cancer	0.000114	0.000527	CcSEcCtD
Rivastigmine—Palpitations—Doxorubicin—bone cancer	0.000114	0.000523	CcSEcCtD
Rivastigmine—Oedema—Epirubicin—bone cancer	0.000113	0.000522	CcSEcCtD
Rivastigmine—Hypotension—Methotrexate—bone cancer	0.000113	0.000521	CcSEcCtD
Rivastigmine—Loss of consciousness—Doxorubicin—bone cancer	0.000113	0.00052	CcSEcCtD
Rivastigmine—Infection—Epirubicin—bone cancer	0.000113	0.000519	CcSEcCtD
Rivastigmine—Cough—Doxorubicin—bone cancer	0.000112	0.000517	CcSEcCtD
Rivastigmine—Shock—Epirubicin—bone cancer	0.000112	0.000514	CcSEcCtD
Rivastigmine—Convulsion—Doxorubicin—bone cancer	0.000111	0.000513	CcSEcCtD
Rivastigmine—Nervous system disorder—Epirubicin—bone cancer	0.000111	0.000512	CcSEcCtD
Rivastigmine—Thrombocytopenia—Epirubicin—bone cancer	0.000111	0.000511	CcSEcCtD
Rivastigmine—Hypertension—Doxorubicin—bone cancer	0.000111	0.000511	CcSEcCtD
Rivastigmine—Tachycardia—Epirubicin—bone cancer	0.000111	0.00051	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00011	0.000508	CcSEcCtD
Rivastigmine—Skin disorder—Epirubicin—bone cancer	0.00011	0.000507	CcSEcCtD
Rivastigmine—Hyperhidrosis—Epirubicin—bone cancer	0.00011	0.000505	CcSEcCtD
Rivastigmine—Insomnia—Methotrexate—bone cancer	0.00011	0.000505	CcSEcCtD
Rivastigmine—Myalgia—Doxorubicin—bone cancer	0.00011	0.000504	CcSEcCtD
Rivastigmine—Chest pain—Doxorubicin—bone cancer	0.00011	0.000504	CcSEcCtD
Rivastigmine—Arthralgia—Doxorubicin—bone cancer	0.00011	0.000504	CcSEcCtD
Rivastigmine—Anxiety—Doxorubicin—bone cancer	0.000109	0.000502	CcSEcCtD
Rivastigmine—Paraesthesia—Methotrexate—bone cancer	0.000109	0.000501	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000109	0.000501	CcSEcCtD
Rivastigmine—Discomfort—Doxorubicin—bone cancer	0.000108	0.000498	CcSEcCtD
Rivastigmine—Anorexia—Epirubicin—bone cancer	0.000108	0.000498	CcSEcCtD
Rivastigmine—Dyspnoea—Methotrexate—bone cancer	0.000108	0.000498	CcSEcCtD
Rivastigmine—Somnolence—Methotrexate—bone cancer	0.000108	0.000496	CcSEcCtD
Rivastigmine—Dry mouth—Doxorubicin—bone cancer	0.000107	0.000493	CcSEcCtD
Rivastigmine—Dyspepsia—Methotrexate—bone cancer	0.000107	0.000491	CcSEcCtD
Rivastigmine—Hypotension—Epirubicin—bone cancer	0.000106	0.000488	CcSEcCtD
Rivastigmine—Confusional state—Doxorubicin—bone cancer	0.000106	0.000487	CcSEcCtD
Rivastigmine—Decreased appetite—Methotrexate—bone cancer	0.000105	0.000485	CcSEcCtD
Rivastigmine—Oedema—Doxorubicin—bone cancer	0.000105	0.000483	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000105	0.000482	CcSEcCtD
Rivastigmine—Fatigue—Methotrexate—bone cancer	0.000105	0.000481	CcSEcCtD
Rivastigmine—Infection—Doxorubicin—bone cancer	0.000104	0.00048	CcSEcCtD
Rivastigmine—Pain—Methotrexate—bone cancer	0.000104	0.000477	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000103	0.000476	CcSEcCtD
Rivastigmine—Shock—Doxorubicin—bone cancer	0.000103	0.000475	CcSEcCtD
Rivastigmine—Nervous system disorder—Doxorubicin—bone cancer	0.000103	0.000474	CcSEcCtD
Rivastigmine—Thrombocytopenia—Doxorubicin—bone cancer	0.000103	0.000473	CcSEcCtD
Rivastigmine—Insomnia—Epirubicin—bone cancer	0.000103	0.000472	CcSEcCtD
Rivastigmine—Tachycardia—Doxorubicin—bone cancer	0.000102	0.000472	CcSEcCtD
Rivastigmine—Skin disorder—Doxorubicin—bone cancer	0.000102	0.000469	CcSEcCtD
Rivastigmine—Paraesthesia—Epirubicin—bone cancer	0.000102	0.000469	CcSEcCtD
Rivastigmine—Hyperhidrosis—Doxorubicin—bone cancer	0.000102	0.000467	CcSEcCtD
Rivastigmine—Dyspnoea—Epirubicin—bone cancer	0.000101	0.000466	CcSEcCtD
Rivastigmine—Somnolence—Epirubicin—bone cancer	0.000101	0.000464	CcSEcCtD
Rivastigmine—Anorexia—Doxorubicin—bone cancer	0.0001	0.000461	CcSEcCtD
Rivastigmine—Feeling abnormal—Methotrexate—bone cancer	9.99e-05	0.00046	CcSEcCtD
Rivastigmine—Dyspepsia—Epirubicin—bone cancer	9.99e-05	0.00046	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Methotrexate—bone cancer	9.92e-05	0.000456	CcSEcCtD
Rivastigmine—Decreased appetite—Epirubicin—bone cancer	9.86e-05	0.000454	CcSEcCtD
Rivastigmine—Hypotension—Doxorubicin—bone cancer	9.81e-05	0.000452	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Epirubicin—bone cancer	9.8e-05	0.000451	CcSEcCtD
Rivastigmine—Fatigue—Epirubicin—bone cancer	9.78e-05	0.00045	CcSEcCtD
Rivastigmine—Pain—Epirubicin—bone cancer	9.7e-05	0.000447	CcSEcCtD
Rivastigmine—Constipation—Epirubicin—bone cancer	9.7e-05	0.000447	CcSEcCtD
Rivastigmine—Urticaria—Methotrexate—bone cancer	9.63e-05	0.000443	CcSEcCtD
Rivastigmine—Abdominal pain—Methotrexate—bone cancer	9.59e-05	0.000441	CcSEcCtD
Rivastigmine—Body temperature increased—Methotrexate—bone cancer	9.59e-05	0.000441	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Doxorubicin—bone cancer	9.57e-05	0.00044	CcSEcCtD
Rivastigmine—Insomnia—Doxorubicin—bone cancer	9.5e-05	0.000437	CcSEcCtD
Rivastigmine—Paraesthesia—Doxorubicin—bone cancer	9.43e-05	0.000434	CcSEcCtD
Rivastigmine—Dyspnoea—Doxorubicin—bone cancer	9.36e-05	0.000431	CcSEcCtD
Rivastigmine—Feeling abnormal—Epirubicin—bone cancer	9.35e-05	0.00043	CcSEcCtD
Rivastigmine—Somnolence—Doxorubicin—bone cancer	9.33e-05	0.00043	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Epirubicin—bone cancer	9.28e-05	0.000427	CcSEcCtD
Rivastigmine—Dyspepsia—Doxorubicin—bone cancer	9.24e-05	0.000425	CcSEcCtD
Rivastigmine—Decreased appetite—Doxorubicin—bone cancer	9.13e-05	0.00042	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Doxorubicin—bone cancer	9.06e-05	0.000417	CcSEcCtD
Rivastigmine—Fatigue—Doxorubicin—bone cancer	9.05e-05	0.000417	CcSEcCtD
Rivastigmine—Urticaria—Epirubicin—bone cancer	9.01e-05	0.000415	CcSEcCtD
Rivastigmine—Constipation—Doxorubicin—bone cancer	8.98e-05	0.000413	CcSEcCtD
Rivastigmine—Pain—Doxorubicin—bone cancer	8.98e-05	0.000413	CcSEcCtD
Rivastigmine—Body temperature increased—Epirubicin—bone cancer	8.97e-05	0.000413	CcSEcCtD
Rivastigmine—Abdominal pain—Epirubicin—bone cancer	8.97e-05	0.000413	CcSEcCtD
Rivastigmine—Hypersensitivity—Methotrexate—bone cancer	8.93e-05	0.000411	CcSEcCtD
Rivastigmine—Asthenia—Methotrexate—bone cancer	8.7e-05	0.0004	CcSEcCtD
Rivastigmine—Feeling abnormal—Doxorubicin—bone cancer	8.65e-05	0.000398	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Doxorubicin—bone cancer	8.59e-05	0.000395	CcSEcCtD
Rivastigmine—Pruritus—Methotrexate—bone cancer	8.58e-05	0.000395	CcSEcCtD
Rivastigmine—Hypersensitivity—Epirubicin—bone cancer	8.36e-05	0.000385	CcSEcCtD
Rivastigmine—Urticaria—Doxorubicin—bone cancer	8.34e-05	0.000384	CcSEcCtD
Rivastigmine—Abdominal pain—Doxorubicin—bone cancer	8.3e-05	0.000382	CcSEcCtD
Rivastigmine—Body temperature increased—Doxorubicin—bone cancer	8.3e-05	0.000382	CcSEcCtD
Rivastigmine—Diarrhoea—Methotrexate—bone cancer	8.3e-05	0.000382	CcSEcCtD
Rivastigmine—Asthenia—Epirubicin—bone cancer	8.14e-05	0.000375	CcSEcCtD
Rivastigmine—Pruritus—Epirubicin—bone cancer	8.03e-05	0.00037	CcSEcCtD
Rivastigmine—Dizziness—Methotrexate—bone cancer	8.02e-05	0.000369	CcSEcCtD
Rivastigmine—Diarrhoea—Epirubicin—bone cancer	7.76e-05	0.000357	CcSEcCtD
Rivastigmine—Hypersensitivity—Doxorubicin—bone cancer	7.74e-05	0.000356	CcSEcCtD
Rivastigmine—Vomiting—Methotrexate—bone cancer	7.71e-05	0.000355	CcSEcCtD
Rivastigmine—Rash—Methotrexate—bone cancer	7.65e-05	0.000352	CcSEcCtD
Rivastigmine—Dermatitis—Methotrexate—bone cancer	7.64e-05	0.000352	CcSEcCtD
Rivastigmine—Headache—Methotrexate—bone cancer	7.6e-05	0.00035	CcSEcCtD
Rivastigmine—Asthenia—Doxorubicin—bone cancer	7.53e-05	0.000347	CcSEcCtD
Rivastigmine—Dizziness—Epirubicin—bone cancer	7.5e-05	0.000345	CcSEcCtD
Rivastigmine—Pruritus—Doxorubicin—bone cancer	7.43e-05	0.000342	CcSEcCtD
Rivastigmine—Vomiting—Epirubicin—bone cancer	7.22e-05	0.000332	CcSEcCtD
Rivastigmine—Nausea—Methotrexate—bone cancer	7.2e-05	0.000331	CcSEcCtD
Rivastigmine—Diarrhoea—Doxorubicin—bone cancer	7.18e-05	0.000331	CcSEcCtD
Rivastigmine—Rash—Epirubicin—bone cancer	7.15e-05	0.000329	CcSEcCtD
Rivastigmine—Dermatitis—Epirubicin—bone cancer	7.15e-05	0.000329	CcSEcCtD
Rivastigmine—Headache—Epirubicin—bone cancer	7.11e-05	0.000327	CcSEcCtD
Rivastigmine—Dizziness—Doxorubicin—bone cancer	6.94e-05	0.00032	CcSEcCtD
Rivastigmine—Nausea—Epirubicin—bone cancer	6.74e-05	0.00031	CcSEcCtD
Rivastigmine—Vomiting—Doxorubicin—bone cancer	6.68e-05	0.000307	CcSEcCtD
Rivastigmine—Rash—Doxorubicin—bone cancer	6.62e-05	0.000305	CcSEcCtD
Rivastigmine—Dermatitis—Doxorubicin—bone cancer	6.61e-05	0.000304	CcSEcCtD
Rivastigmine—Headache—Doxorubicin—bone cancer	6.58e-05	0.000303	CcSEcCtD
Rivastigmine—Nausea—Doxorubicin—bone cancer	6.24e-05	0.000287	CcSEcCtD
